TGTX logo

TG Therapeutics, Inc. (TGTX) Retained Earnings

Annual Retained Earnings:

-$1.53B+$23.38M(+1.51%)
December 31, 2024

Summary

  • As of today, TGTX annual retained earnings is -$1.53 billion, with the most recent change of +$23.38 million (+1.51%) on December 31, 2024.
  • During the last 3 years, TGTX annual retained earnings has fallen by -$200.50 million (-15.09%).
  • TGTX annual retained earnings is now -179151.44% below its all-time high of -$853.10 thousand, reached on December 31, 2011.

Performance

TGTX Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXbalance sheet metrics

Quarterly Retained Earnings:

-$1.50B+$28.19M(+1.85%)
June 30, 2025

Summary

  • As of today, TGTX quarterly retained earnings is -$1.50 billion, with the most recent change of +$28.19 million (+1.85%) on June 30, 2025.
  • Over the past year, TGTX quarterly retained earnings has increased by +$60.46 million (+3.88%).
  • TGTX quarterly retained earnings is now -175254.24% below its all-time high of -$853.10 thousand, reached on December 31, 2011.

Performance

TGTX Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXbalance sheet metrics

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

TGTX Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+1.5%+3.9%
3Y3 Years-15.1%-4.0%
5Y5 Years-118.1%-85.8%

TGTX Retained Earnings Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-15.1%+1.5%-1.5%+7.3%
5Y5-Year-118.1%+1.5%-67.6%+7.3%
All-TimeAll-Time>-9999.0%+1.5%>-9999.0%+7.3%

TGTX Retained Earnings History

DateAnnualQuarterly
Jun 2025
-
-$1.50B(+1.8%)
Mar 2025
-
-$1.52B(+0.3%)
Dec 2024
-$1.53B(+1.5%)
-$1.53B(+1.5%)
Sep 2024
-
-$1.55B(+0.2%)
Jun 2024
-
-$1.56B(-2.1%)
Mar 2024
-
-$1.53B(-0.7%)
Dec 2023
-$1.55B(-1.7%)
-$1.51B(-1.0%)
Sep 2023
-
-$1.50B(+7.1%)
Jun 2023
-
-$1.61B(-3.0%)
Mar 2023
-
-$1.57B(-2.6%)
Dec 2022
-$1.53B(-14.9%)
-$1.53B(-3.6%)
Sep 2022
-
-$1.47B(-2.5%)
Jun 2022
-
-$1.44B(-2.9%)
Mar 2022
-
-$1.40B(-5.2%)
Dec 2021
-$1.33B(-35.5%)
-$1.33B(-7.6%)
Sep 2021
-
-$1.24B(-7.4%)
Jun 2021
-
-$1.15B(-7.3%)
Mar 2021
-
-$1.07B(-9.2%)
Dec 2020
-$980.60M(-39.8%)
-$980.60M(-9.9%)
Sep 2020
-
-$892.38M(-10.8%)
Jun 2020
-
-$805.22M(-7.0%)
Mar 2020
-
-$752.33M(-7.3%)
Dec 2019
-$701.22M(-32.7%)
-$701.22M(-6.0%)
Sep 2019
-
-$661.64M(-10.3%)
Jun 2019
-
-$599.71M(-6.4%)
Mar 2019
-
-$563.50M(-6.7%)
Dec 2018
-$528.35M(-48.9%)
-$528.35M(-11.4%)
Sep 2018
-
-$474.49M(-7.7%)
Jun 2018
-
-$440.53M(-11.1%)
Mar 2018
-
-$396.39M(-11.7%)
Dec 2017
-$354.86M(-50.1%)
-$354.86M(-9.5%)
Sep 2017
-
-$324.00M(-10.8%)
Jun 2017
-
-$292.47M(-10.7%)
Mar 2017
-
-$264.11M(-11.7%)
Dec 2016
-$236.39M(-49.5%)
-$236.39M(-11.1%)
Sep 2016
-
-$212.71M(-13.2%)
Jun 2016
-
-$187.88M(-9.2%)
Mar 2016
-
-$171.98M(-8.8%)
Dec 2015
-$158.13M(-66.1%)
-$158.13M(-12.5%)
Sep 2015
-
-$140.52M(-10.8%)
Jun 2015
-
-$126.87M(-15.6%)
Mar 2015
-
-$109.76M(-15.3%)
Dec 2014
-$95.19M(-141.6%)
-$95.19M(-24.6%)
Sep 2014
-
-$76.39M(-29.6%)
Jun 2014
-
-$58.94M(-25.5%)
Mar 2014
-
-$46.95M(-19.2%)
Dec 2013
-$39.40M(-108.2%)
-$39.40M(-16.8%)
Sep 2013
-
-$33.74M(-15.6%)
Jun 2013
-
-$29.18M(-29.1%)
Mar 2013
-
-$22.60M(-19.4%)
Dec 2012
-$18.93M(-2118.5%)
-$18.93M(-22.4%)
Sep 2012
-
-$15.47M(-18.9%)
Jun 2012
-
-$13.00M(-17.1%)
Mar 2012
-
-$11.11M(-1202.2%)
Dec 2011
-$853.10K(+98.6%)
-$853.10K(+98.6%)
Sep 2011
-
-$61.01M(-0.9%)
Jun 2011
-
-$60.46M(-5.2%)
Mar 2011
-
-$57.48M(+6.3%)
DateAnnualQuarterly
Dec 2010
-$61.31M(+1.0%)
-$61.31M(+0.6%)
Sep 2010
-
-$61.67M(+0.1%)
Jun 2010
-
-$61.72M(+2.9%)
Mar 2010
-
-$63.57M(-2.6%)
Dec 2009
-$61.93M(-4.5%)
-$61.93M(-0.4%)
Sep 2009
-
-$61.71M(-0.7%)
Jun 2009
-
-$61.29M(-2.3%)
Mar 2009
-
-$59.90M(-1.1%)
Dec 2008
-$59.27M(-7.8%)
-$59.27M(+0.2%)
Sep 2008
-
-$59.39M(-2.4%)
Jun 2008
-
-$58.00M(-2.5%)
Mar 2008
-
-$56.56M(-2.8%)
Dec 2007
-$55.00M(-28.0%)
-$55.00M(-3.6%)
Sep 2007
-
-$53.09M(-5.3%)
Jun 2007
-
-$50.43M(-10.7%)
Mar 2007
-
-$45.53M(-6.0%)
Dec 2006
-$42.97M(-29.1%)
-$42.97M(-7.9%)
Sep 2006
-
-$39.84M(-5.0%)
Jun 2006
-
-$37.94M(-5.1%)
Mar 2006
-
-$36.09M(-8.5%)
Dec 2005
-$33.27M(-138.4%)
-$33.27M(-7.7%)
Sep 2005
-
-$30.88M(-6.5%)
Jun 2005
-
-$28.99M(-87.0%)
Mar 2005
-
-$15.51M(-11.1%)
Dec 2004
-$13.96M(-86.7%)
-$13.96M(-15.1%)
Sep 2004
-
-$12.12M(-23.4%)
Jun 2004
-
-$9.82M(-11.9%)
Mar 2004
-
-$8.78M(-17.5%)
Dec 2003
-$7.47M(-583.0%)
-$7.47M(-34.8%)
Sep 2003
-
-$5.55M(-141.9%)
Jun 2003
-
-$2.29M(-51.2%)
Mar 2003
-
-$1.52M(+94.6%)
Dec 2002
-$1.09M(+95.9%)
-$28.28M(-1.3%)
Sep 2002
-
-$27.91M(-2.2%)
Jun 2002
-
-$27.32M(+0.1%)
Mar 2002
-
-$27.35M(-2.3%)
Dec 2001
-$26.73M(-7.7%)
-$26.73M(-2.2%)
Sep 2001
-
-$26.16M(-2.9%)
Jun 2001
-
-$25.43M(-9.1%)
Mar 2001
-
-$23.31M(+6.1%)
Dec 2000
-$24.83M(-32.1%)
-$24.82M(-2.5%)
Sep 2000
-
-$24.23M(-4.2%)
Jun 2000
-
-$23.26M(-15.3%)
Mar 2000
-
-$20.17M(-7.3%)
Dec 1999
-$18.80M(-15.3%)
-$18.79M(-3.3%)
Sep 1999
-
-$18.19M(-1.9%)
Jun 1999
-
-$17.86M(-3.7%)
Mar 1999
-
-$17.21M(-5.3%)
Dec 1998
-$16.30M(-20.7%)
-$16.34M(-8.6%)
Sep 1998
-
-$15.05M(-8.8%)
Jun 1998
-
-$13.84M(+6.9%)
Mar 1998
-
-$14.86M(-10.1%)
Dec 1997
-$13.50M(-60.7%)
-$13.50M(-11.6%)
Sep 1997
-
-$12.10M(-7.1%)
Jun 1997
-
-$11.30M(-20.2%)
Mar 1997
-
-$9.40M(-11.9%)
Dec 1996
-$8.40M
-$8.40M(-12.0%)
Sep 1996
-
-$7.50M(-17.2%)
Jun 1996
-
-$6.40M

FAQ

  • What is TG Therapeutics, Inc. annual retained earnings?
  • What is the all-time high annual retained earnings for TG Therapeutics, Inc.?
  • What is TG Therapeutics, Inc. annual retained earnings year-on-year change?
  • What is TG Therapeutics, Inc. quarterly retained earnings?
  • What is the all-time high quarterly retained earnings for TG Therapeutics, Inc.?
  • What is TG Therapeutics, Inc. quarterly retained earnings year-on-year change?

What is TG Therapeutics, Inc. annual retained earnings?

The current annual retained earnings of TGTX is -$1.53B

What is the all-time high annual retained earnings for TG Therapeutics, Inc.?

TG Therapeutics, Inc. all-time high annual retained earnings is -$853.10K

What is TG Therapeutics, Inc. annual retained earnings year-on-year change?

Over the past year, TGTX annual retained earnings has changed by +$23.38M (+1.51%)

What is TG Therapeutics, Inc. quarterly retained earnings?

The current quarterly retained earnings of TGTX is -$1.50B

What is the all-time high quarterly retained earnings for TG Therapeutics, Inc.?

TG Therapeutics, Inc. all-time high quarterly retained earnings is -$853.10K

What is TG Therapeutics, Inc. quarterly retained earnings year-on-year change?

Over the past year, TGTX quarterly retained earnings has changed by +$60.46M (+3.88%)
On this page